An Exclusive Interview with Mr. Mannuri Vamshi krishna, Founder & CEO of SafeCredits, a full-stack B2B trade credit intelligence and distributor monitoring platform
We delve into an interview with Mr. Mannuri Vamshi Krishna, Founder & CEO of SafeCredits, a cutting-edge platform providing full-stack B2B trade credit intelligence and distributor monitoring solutions.
What inspired you to start working in a medical store at age 13 after your father’s passing, and how did that shape SafeCredits’ mission?
Mannuri Vamshi Krishna: Losing my father at a very young age forced me to take responsibility early, which led me to start working at a medical store when I was just 13. Over time, that initial experience grew into hands-on exposure across the pharma distribution and supply chain, from retail counters to wholesale operations, and eventually running my own supply chain business.
This journey offered a complete, ground-level understanding of how trade credit actually functions in real life, where growth often runs on trust but lacks visibility into risk, customer strength, or early warning signals. Witnessing how delayed payments and bad debts disrupted not only individual businesses but entire supply chains made a lasting impact.
SafeCredits emerged from that lived reality with a clear purpose to transform credit into a structured growth enabler rather than a blind risk, allowing businesses to grow with confidence, safeguard cash flows, and build stronger, more sustainable trade relationships.
Walk us through the evolution from Medvolant (MedxBid) and MedScore to launching SafeCredits as a sector-agnostic platform.
Mannuri Vamshi Krishna: The journey began with Medvolant, also known as MedxBid, with the aim of improving efficiency in pharma procurement, but while building the platform it became clear that supply was not the real constraint. The deeper issue was uncertainty around credit, which slowed decision making and limited growth.
That realization led to the creation of MedScore, a credit intelligence solution focused specifically on the pharma ecosystem. As MedScore gained adoption, a broader pattern emerged where delayed payments and bad debts were not confined to one sector but were a shared challenge across industries.
This understanding naturally shaped the launch of SafeCredits as a sector-agnostic platform built for businesses operating through distributor and dealer networks. It moves beyond simple credit scoring to help organizations plan more confidently, grow responsibly, and scale without exposing themselves to hidden financial risk.
MedScore filed a patent for its scoring mechanism what unique features does SafeCredits build on this for broader industries?
Mannuri Vamshi Krishna: The patented MedScore mechanism established a strong foundation in behavior based credit intelligence, and SafeCredits builds on that by evolving into a complete end to end business decision platform rather than remaining just a scoring engine.
It enables seamless digital onboarding of customers and distributors, offers continuous monitoring of performance, payment behavior, and exposure, and provides clear visibility into credit health at both individual and network levels.
On top of this, AI driven recommendations support sales and credit teams in identifying where growth is safe, when credit discipline needs tightening, and how to balance ambitious sales goals with risk management.
In essence, SafeCredits goes beyond identifying risk and actively guides the right commercial and credit actions, allowing businesses to grow with confidence while staying protected.
How does SafeCredits tackle bad debts and delayed payments in India’s underdeveloped pharma credit infrastructure?
Mannuri Vamshi Krishna: India’s pharma credit ecosystem still runs largely on informal trust, which means visibility is limited, payments get delayed, and default risk can climb to 10 or even 12 percent.
SafeCredits steps in right from the first interaction with a distributor, focusing on verifying the business, understanding its stability, and creating a data backed credit report at the onboarding stage.
From there, a practical credit limit is recommended based on real risk and performance indicators rather than assumptions. As relationships progress, the platform keeps a close watch on day to day transactions and payment behavior, flags early warning signs, leakages, and stress points, and offers AI driven guidance to help teams make better credit, collections, and sales decisions.
Automated reminders, IVR calls, and structured escalation workflows add discipline without damaging relationships. The outcome is a system that helps businesses meaningfully reduce bad debts while still growing revenue in a safe and sustainable way.
What role did incubators like IIM Udaipur and ISAR University play in scaling from ₹2.1 Crore angel funding to raising $1M?
Mannuri Vamshi Krishna: Incubators like the IIM Udaipur Incubation Centre and ISAR University have played a meaningful role in shaping our growth journey and preparing us for scale.
Through the IIM Udaipur Incubation Centre, we secured ₹30 lakhs under the MeitY program, which helped accelerate product development and early traction for SafeCredits.
Beyond funding, the ongoing support has come through investor connections for the one million dollar round, access to government grants and wider funding networks, and entry into both government and corporate ecosystems.
Structured mentorship and strategic guidance at critical stages have also helped sharpen execution and decision making. This sustained backing has significantly strengthened our readiness for institutional capital and supported the transition from early angel funding to a larger growth phase.
How does SafeCredits’ network of 400+ vendors and 150 hospitals expand into FMCG and manufacturing?
Mannuri Vamshi Krishna: While SafeCredits has built strong traction with over 400 vendors and 150 hospitals, the platform was never designed to be limited to healthcare alone. The underlying credit and distribution challenges are similar across industries that rely on dealer, distributor, or franchise networks.
SafeCredits is already structured to serve sectors such as FMCG and consumer goods, manufacturing and industrial supplies, automotive and tyre businesses, electronics, hardware, building materials, and even logistics driven B2B trade ecosystems.
In any environment where credit fuels distribution, the platform brings visibility, discipline, and alignment between sales growth and risk, making it equally relevant beyond healthcare as it is within it.
What partnerships or investments are you seeking next to make credit risk management a standard across India’s supply chains?
Mannuri Vamshi Krishna: The next phase is focused on building partnerships and investments that can help embed credit risk management deeply into India’s supply chains.
The priority is to work with strategic investors who understand fintech, supply chains, and the MSME ecosystem, alongside large corporates that manage extensive distributor networks.
Collaborations with NBFCs, banks, ERP providers, and industry bodies are also critical to creating a connected and scalable ecosystem.
The larger vision is to position SafeCredits as the go-to platform for corporates, one that simplifies risk management, empowers sales teams, and helps businesses achieve their growth targets with confidence. Credit intelligence should not be an add on but a standard operating layer across India’s supply chains.
In conclusion, Mr. Vamshi Krishna offered invaluable insights into B2B trade credit risk and the innovative future of SafeCredits in stabilizing and optimizing the distributor ecosystem.
| Are you an
Entrepreneur or Startup? Do you have a Success Story to Share? SugerMint would like to share your success story. We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
|
Read more Success stories of Indian entrepreneurs, Women Entrepreneurs & startups stories at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn